PerspectiveLIMITING RISK

Disciplined approach to drug discovery and early development

See allHide authors and affiliations

Science Translational Medicine  27 Jul 2016:
Vol. 8, Issue 349, pp. 349ps15
DOI: 10.1126/scitranslmed.aaf2608

Article Information

vol. 8 no. 349 349ps15

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication February 17, 2016
  • Accepted for publication July 7, 2016

Author Information

  1. Robert M. Plenge
  1. Merck Research Laboratories, Boston, MA 02115, USA. Email: robert.plenge{at}merck.com

Altmetric

Article usage

Article usage: July 2016 to December 2017

AbstractFullPdf
Jul 2016356211941676
Aug 2016229341364091
Sep 2016378474478
Oct 2016259196265
Nov 2016178127172
Dec 2016179134168
Jan 20171468093
Feb 201712486105
Mar 2017214104164
Apr 2017233150147
May 2017186137132
Jun 201710568112
Jul 201710579129
Aug 20179884116
Sep 2017915865
Oct 20171137776
Nov 20171126656
Dec 2017482430